日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer

采用白蛋白结合型紫杉醇和拓扑替康的双重节拍化疗方案对卵巢癌具有强大的抗血管生成活性

Previs, Rebecca A; Armaiz-Pena, Guillermo N; Lin, Yvonne G; Davis, Ashley N; Pradeep, Sunila; Dalton, Heather J; Hansen, Jean M; Merritt, William M; Nick, Alpa M; Langley, Robert R; Coleman, Robert L; Sood, Anil K

A novel platform for detection of CK+ and CK- CTCs

一种用于检测 CK+ 和 CK- CTC 的新型平台

Pecot, Chad V; Bischoff, Farideh Z; Mayer, Julie Ann; Wong, Karina L; Pham, Tam; Bottsford-Miller, Justin; Stone, Rebecca L; Lin, Yvonne G; Jaladurgam, Padmavathi; Roh, Ju Won; Goodman, Blake W; Merritt, William M; Pircher, Tony J; Mikolajczyk, Stephen D; Nick, Alpa M; Celestino, Joseph; Eng, Cathy; Ellis, Lee M; Deavers, Michael T; Sood, Anil K

Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer

利用节拍式拓扑替康和帕唑帕尼治疗卵巢癌,弥合细胞毒性药物和生物疗法之间的差距

Merritt, William M; Nick, Alpa M; Carroll, Amy R; Lu, Chunhua; Matsuo, Koji; Dumble, Melissa; Jennings, Nicholas; Zhang, Shuyun; Lin, Yvonne G; Spannuth, Whitney A; Kamat, Aparna A; Stone, Rebecca L; Shahzad, Mian M K; Coleman, Robert L; Kumar, Rakesh; Sood, Anil K

Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma

来自平行 EphB4 靶向治疗卵巢癌的疗效证据不断汇聚

Spannuth, Whitney A; Mangala, Lingegowda S; Stone, Rebecca L; Carroll, Amy R; Nishimura, Masato; Shahzad, Mian M K; Lee, Sun-Joo; Moreno-Smith, Myrthala; Nick, Alpa M; Liu, Ren; Jennings, Nicholas B; Lin, Yvonne G; Merritt, William M; Coleman, Robert L; Vivas-Mejia, Pablo E; Zhou, Yue; Krasnoperov, Valery; Lopez-Berestein, Gabriel; Gill, Parkash S; Sood, Anil K

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

EphA2 过表达和血管生成对子宫内膜癌的临床和生物学影响

Merritt, William M; Kamat, Aparna A; Hwang, Jee-Young; Bottsford-Miller, Justin; Lu, Chunhua; Lin, Yvonne G; Coffey, Donna; Spannuth, Whitney A; Nugent, Elizabeth; Han, Liz Y; Landen, Charles N; Nick, Alpa M; Stone, Rebecca L; Coffman, Karen; Bruckheimer, Elizabeth; Broaddus, Russell R; Gershenson, David M; Coleman, Robert L; Sood, Anil K

EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer

EphA2 过表达与子宫内膜癌中激素受体表达缺乏和不良预后相关。

Kamat, Aparna A; Coffey, Donna; Merritt, William M; Nugent, Elizabeth; Urbauer, Diana; Lin, Yvonne G; Edwards, Creighton; Broaddus, Russell; Coleman, Robert L; Sood, Anil K

Functional significance of VEGFR-2 on ovarian cancer cells

VEGFR-2在卵巢癌细胞中的功能意义

Spannuth, Whitney A; Nick, Alpa M; Jennings, Nicholas B; Armaiz-Pena, Guillermo N; Mangala, Lingegowda S; Danes, Christopher G; Lin, Yvonne G; Merritt, William M; Thaker, Premal H; Kamat, Aparna A; Han, Liz Y; Tonra, James R; Coleman, Robert L; Ellis, Lee M; Sood, Anil K

Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer

在卵巢癌原位模型中,联合应用抗血管内皮生长因子(VEGF)和整合素αVβ3的抗血管生成疗法

Kim, Tae Jin; Landen, Charles N; Lin, Yvonne G; Mangala, Lingegowda S; Lu, Chunhua; Nick, Alpa M; Stone, Rebecca L; Merritt, William M; Armaiz-Pena, Guillermo; Jennings, Nicholas B; Coleman, Robert L; Tice, David A; Sood, Anil K

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.

利用脂质体包裹的小干扰RNA沉默白细胞介素-8基因对卵巢癌细胞生长的影响

Merritt William M, Lin Yvonne G, Spannuth Whitney A, Fletcher Mavis S, Kamat Aparna A, Han Liz Y, Landen Charles N, Jennings Nicholas, De Geest Koen, Langley Robert R, Villares Gabriel, Sanguino Angela, Lutgendorf Susan K, Lopez-Berestein Gabriel, Bar-Eli Menashe M, Sood Anil K

Markers of angiogenesis in ovarian cancer

卵巢癌血管生成标志物

Merritt, William M; Sood, Anil K